Movement Disorders Associated with COVID-19

As neurological complications associated with COVID-19 keep unfolding, the number of cases with COVID-19-associated de novo movement disorders is rising. Although no clear pathomechanistic explanation is provided yet, the growing number of these cases is somewhat alarming. This review gathers inform...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mehri Salari, Bahareh Zaker Harofteh, Masoud Etemadifar, Nahad Sedaghat, Hosein Nouri
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi Limited 2021
Materias:	Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/439c9ba4c5ca4887acc38efadaf3df85
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:439c9ba4c5ca4887acc38efadaf3df85
record_format	dspace
spelling	oai:doaj.org-article:439c9ba4c5ca4887acc38efadaf3df852021-11-22T01:10:14ZMovement Disorders Associated with COVID-192042-008010.1155/2021/3227753https://doaj.org/article/439c9ba4c5ca4887acc38efadaf3df852021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/3227753https://doaj.org/toc/2042-0080As neurological complications associated with COVID-19 keep unfolding, the number of cases with COVID-19-associated de novo movement disorders is rising. Although no clear pathomechanistic explanation is provided yet, the growing number of these cases is somewhat alarming. This review gathers information from 64 reports of de novo movement disorders developing after/during infection with SARS-CoV-2. Three new cases with myoclonus occurring shortly after a COVID-19 infection are also presented. Treatment resulted in partial to complete recovery in all three cases. Although the overall percentage of COVID-19 patients who develop movement disorders is marginal, explanations on a probable causal link have been suggested by numerous reports; most commonly involving immune-mediated and postinfectious and less frequently hypoxic-associated and ischemic-related pathways. The current body of evidence points myoclonus and ataxia out as the most frequent movement disorders occurring in COVID-19 patients. Some cases of tremor, chorea, and hypokinetic-rigid syndrome have also been observed in association with COVID-19. In particular, parkinsonism may be of dual concern in the setting of COVID-19; some have linked viral infections with Parkinson’s disease (PD) based on results from cerebrospinal fluid analyses, and PD is speculated to impact the outcome of COVID-19 in patients negatively. In conclusion, the present paper reviewed the demographic, clinical, and treatment-associated information on de novo movement disorders in COVID-19 patients in detail; it also underlined the higher incidence of myoclonus and ataxia associated with COVID-19 than other movement disorders.Mehri SalariBahareh Zaker HaroftehMasoud EtemadifarNahad SedaghatHosein NouriHindawi LimitedarticleNeurology. Diseases of the nervous systemRC346-429ENParkinson's Disease, Vol 2021 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurology. Diseases of the nervous system RC346-429 Mehri Salari Bahareh Zaker Harofteh Masoud Etemadifar Nahad Sedaghat Hosein Nouri Movement Disorders Associated with COVID-19
description	As neurological complications associated with COVID-19 keep unfolding, the number of cases with COVID-19-associated de novo movement disorders is rising. Although no clear pathomechanistic explanation is provided yet, the growing number of these cases is somewhat alarming. This review gathers information from 64 reports of de novo movement disorders developing after/during infection with SARS-CoV-2. Three new cases with myoclonus occurring shortly after a COVID-19 infection are also presented. Treatment resulted in partial to complete recovery in all three cases. Although the overall percentage of COVID-19 patients who develop movement disorders is marginal, explanations on a probable causal link have been suggested by numerous reports; most commonly involving immune-mediated and postinfectious and less frequently hypoxic-associated and ischemic-related pathways. The current body of evidence points myoclonus and ataxia out as the most frequent movement disorders occurring in COVID-19 patients. Some cases of tremor, chorea, and hypokinetic-rigid syndrome have also been observed in association with COVID-19. In particular, parkinsonism may be of dual concern in the setting of COVID-19; some have linked viral infections with Parkinson’s disease (PD) based on results from cerebrospinal fluid analyses, and PD is speculated to impact the outcome of COVID-19 in patients negatively. In conclusion, the present paper reviewed the demographic, clinical, and treatment-associated information on de novo movement disorders in COVID-19 patients in detail; it also underlined the higher incidence of myoclonus and ataxia associated with COVID-19 than other movement disorders.
format	article
author	Mehri Salari Bahareh Zaker Harofteh Masoud Etemadifar Nahad Sedaghat Hosein Nouri
author_facet	Mehri Salari Bahareh Zaker Harofteh Masoud Etemadifar Nahad Sedaghat Hosein Nouri
author_sort	Mehri Salari
title	Movement Disorders Associated with COVID-19
title_short	Movement Disorders Associated with COVID-19
title_full	Movement Disorders Associated with COVID-19
title_fullStr	Movement Disorders Associated with COVID-19
title_full_unstemmed	Movement Disorders Associated with COVID-19
title_sort	movement disorders associated with covid-19
publisher	Hindawi Limited
publishDate	2021
url	https://doaj.org/article/439c9ba4c5ca4887acc38efadaf3df85
work_keys_str_mv	AT mehrisalari movementdisordersassociatedwithcovid19 AT baharehzakerharofteh movementdisordersassociatedwithcovid19 AT masoudetemadifar movementdisordersassociatedwithcovid19 AT nahadsedaghat movementdisordersassociatedwithcovid19 AT hoseinnouri movementdisordersassociatedwithcovid19
_version_	1718418335092178944

Movement Disorders Associated with COVID-19

Ejemplares similares